Home

NEWS

July 12, 2023

A paper of Professor Hiroaki Shimokawa, Founder, Chairman & CMO of SWI, has been published online in the journal PLOS ONE.

A paper on a pilot clinical trial investigating the efficacy and safety of LIPUS treatment for severe angina pectoris by research group (Tohoku University) led by Professor Hiroaki Shimokawa, Founder, Chairman & CMO of SWI, has been published online in the journal PLOS ONE (electronic version) on June 23, 2023.

We are leading the development and commercialization of the LIPUS treatment device.

Article title:
A randomized, double-blind, placebo-controlled pilot trial of low-intensity pulsed ultrasound therapy for refractory angina pectoris

Authors:
Tomohiko Shindo, Kenta Ito, Tsuyoshi Ogata, Ryo Kurosawa, Kumiko Eguchi, Yuta Kagaya, Kenichiro Hanawa, Yuhi Hasebe,Kensuke Nishimiya, Takashi Shiroto, Jun Takahashi, Yasuo Okumura, Teruo Noguchi, Yukio Ozaki, Hiroyuki Daida, Nobuhisa Hagiwara, Tohru Masuyama, Taishiro Chikamori, Yoshihiro Fukumoto, Kenichi Tsujita, Hiroshi Kanai, Satoshi Yasuda, Hiroaki Shimokawa

Journal name:PLOS ONE
DOI: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287714

Contact information
Sound Wave Innovation Co., Ltd.
mailinfo@sw-innovation.com